AXIM BIOTECHNOLOGIES, INC. (AXIM) Return on equity
AXIM BIOTECHNOLOGIES, INC. (AXIM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-409.4%FY2020
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -409.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net incomeAXIM Net marginAXIM Gross profitAXIM Gross marginAXIM Operating incomeAXIM Operating marginAXIM Operating cash flowAXIM Free cash flowAXIM Capital expendituresAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →